525
Participants
Start Date
August 1, 2022
Primary Completion Date
July 31, 2023
Study Completion Date
August 31, 2023
Audit-and-feedback
We will provide feedback both at baseline and at regular intervals to the 3 intervention sites. At first, we will schedule one-on-one conference calls with urology providers and the antimicrobial stewardship team at each of the 3 intervention sites. These conference calls will include a review of guidelines, a review of the facility's data on excessive post-procedural antimicrobial use for urologic patients, and an anonymous comparison to all other VHA sites. Next, we will prospectively monitor excessive post-procedural antimicrobial use at all 3 sites and the entire VHA for 1 year. Data on hospital-level excessive post-procedural antimicrobial use specific to urologic patients (primary outcome) will be sent electronically to urology providers and the antimicrobial stewardship team at the intervention site every other month via electronic mail.
VA New York Harbor Healthcare System (Brooklyn), New York
Iowa City VA Medical Center, Iowa City
VA North Florida/South Georgia Veterans Health System, Gainesville
Merck Sharp & Dohme LLC
INDUSTRY
Iowa City Veterans Affairs Medical Center
FED